Ann Tanabe
Vorstandsvorsitzender bei BioHouston, Inc.
Profil
Ann Tanabe is currently the Chief Executive Officer at BioHouston, Inc. and is also a member of the National Investor Relations Institute.
She previously worked as the VP-Investor Relations & Corporate Communications at Encysive Pharmaceuticals, Inc. from 2000 to 2011, as the Investor Relations Manager at Rochem Environmental, Inc. from 1994 to 2000, and as the Vice President-Investor Relations at Synthesis Energy Systems, Inc. in 2010.
Ms. Tanabe received her undergraduate degree from Marymount University in 1990.
Aktive Positionen von Ann Tanabe
Unternehmen | Position | Beginn |
---|---|---|
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Corporate Officer/Principal | - |
BioHouston, Inc.
BioHouston, Inc. Miscellaneous Commercial ServicesCommercial Services BioHouston, Inc. engages in life science and biotechnology commercialization. The firm's mission is to create an environment that will stimulate technology transfer and research commercialization, thereby generating economic wealth for the Houston region and making it a global competitor in life science commercialization. The company is headquartered in Houston, TX. | Vorstandsvorsitzender | 01.10.2015 |
Ehemalige bekannte Positionen von Ann Tanabe
Unternehmen | Position | Ende |
---|---|---|
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Public Communications Contact | 29.04.2011 |
SYNTHESIS ENERGY SYSTEMS, INC. | Public Communications Contact | 01.12.2010 |
Rochem Environmental, Inc.
Rochem Environmental, Inc. Industrial MachineryProducer Manufacturing Rochem Environmental, Inc. provides industrial wastewater treatment services and capital equipment to companies in the refining, petrochemical and oil & gas industries. Its patented technology 'Disc Tube' system involves the use of a Disc Tube form of membrane separation modules. The company also utilizes patented ultra filtration technology 'FM Module' system from Rochem UF. It believes these processes are superior to other technologies in their ability to cost-effectively treat a wide variety of wastewaters with the recovery of relatively pure water and the concentration of products and by-product materials for reuse or disposal. The company utilizes these products on a non-exclusive basis. | Public Communications Contact | 10.01.2000 |
Ausbildung von Ann Tanabe
Marymount University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SYNTHESIS ENERGY SYSTEMS, INC. | Process Industries |
Private Unternehmen | 4 |
---|---|
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Health Technology |
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Commercial Services |
Rochem Environmental, Inc.
Rochem Environmental, Inc. Industrial MachineryProducer Manufacturing Rochem Environmental, Inc. provides industrial wastewater treatment services and capital equipment to companies in the refining, petrochemical and oil & gas industries. Its patented technology 'Disc Tube' system involves the use of a Disc Tube form of membrane separation modules. The company also utilizes patented ultra filtration technology 'FM Module' system from Rochem UF. It believes these processes are superior to other technologies in their ability to cost-effectively treat a wide variety of wastewaters with the recovery of relatively pure water and the concentration of products and by-product materials for reuse or disposal. The company utilizes these products on a non-exclusive basis. | Producer Manufacturing |
BioHouston, Inc.
BioHouston, Inc. Miscellaneous Commercial ServicesCommercial Services BioHouston, Inc. engages in life science and biotechnology commercialization. The firm's mission is to create an environment that will stimulate technology transfer and research commercialization, thereby generating economic wealth for the Houston region and making it a global competitor in life science commercialization. The company is headquartered in Houston, TX. | Commercial Services |